Enovid therapy (norethynodrel with mestranol) for fibrocystic disease.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001835:Body Weight / Q000187:drug effects; D001941:Breast Diseases / Q000139:chemically induced / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000209:etiology; D003560:Cysts / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D008593:Menopause; D008656:Mestranol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009641:Norethynodrel / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011230:Precancerous Conditions / Q000139:chemically induced; D013924:Thrombophlebitis / Q000139:chemically induced
D009641:Norethynodrel; D008656:Mestranol